These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

822 related items for PubMed ID: 25326748

  • 21. Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 Patients.
    Piccolo R, Pilgrim T, Heg D, Franzone A, Rat-Wirtzler J, Räber L, Silber S, Serruys PW, Jüni P, Windecker S.
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1657-66. PubMed ID: 26585615
    [Abstract] [Full Text] [Related]

  • 22. One-year follow-up of patients treated with new-generation polymer-based 38 mm everolimus-eluting stent: the P38 study.
    Sgueglia GA, Belloni F, Summaria F, Conte M, Cortese B, Silva PL, Ricci R, Lioy E, Pucci E, Gaspardone A.
    Catheter Cardiovasc Interv; 2015 Feb 01; 85(2):218-24. PubMed ID: 24824088
    [Abstract] [Full Text] [Related]

  • 23. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q, Wang XL, Liao ML, Hu J, Yang ZK, Ding FH, Zhang JS, Du R, Zhu TQ, Shen WF, Zhang RY.
    Catheter Cardiovasc Interv; 2015 Mar 01; 85 Suppl 1():762-9. PubMed ID: 25630513
    [Abstract] [Full Text] [Related]

  • 24. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL, Han YL, Zhang YJ, Ye F, Liu HW, Zhang JJ, Xu B, Jiang TM, Zhou YJ, Lv SZ.
    JACC Cardiovasc Interv; 2013 Dec 01; 6(12):1233-41. PubMed ID: 24239199
    [Abstract] [Full Text] [Related]

  • 25. Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial.
    Jensen LO, Thayssen P, Maeng M, Christiansen EH, Ravkilde J, Hansen KN, Kaltoft A, Tilsted HH, Madsen M, Lassen JF, Scandinavian Organization for Randomized Trials With Clinical Outcome SORT OUT IV Investigators.
    JACC Cardiovasc Interv; 2014 Aug 01; 7(8):840-8. PubMed ID: 25086842
    [Abstract] [Full Text] [Related]

  • 26. Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
    Généreux P, Bettinger N, Redfors B, Lee AC, Kim CY, Lee MS, Shlofmitz RA, Moses JW, Stone GW, Chambers JW.
    Catheter Cardiovasc Interv; 2016 Sep 01; 88(3):369-77. PubMed ID: 27084293
    [Abstract] [Full Text] [Related]

  • 27. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E, Mangiacapra F, Peace A, Ntarladimas Y, Conte M, Bartunek J, Vanderheyden M, Wijns W, de Bruyne B, Barbato E.
    Arch Cardiovasc Dis; 2013 Nov 01; 106(11):554-61. PubMed ID: 24231052
    [Abstract] [Full Text] [Related]

  • 28. Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study.
    Cassese S, De Luca G, Villari B, Berti S, Bellone P, Alfieri A, Montinaro A, Quaranta G, Marraccini P, Piscione F, MATRIX Study Investigators.
    Catheter Cardiovasc Interv; 2012 Sep 01; 80(3):408-16. PubMed ID: 21735531
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The long-term clinical outcome of T-stenting and small protrusion technique for coronary bifurcation lesions.
    Naganuma T, Latib A, Basavarajaiah S, Chieffo A, Figini F, Carlino M, Montorfano M, Godino C, Ferrarello S, Hasegawa T, Kawaguchi M, Nakamura S, Colombo A.
    JACC Cardiovasc Interv; 2013 Jun 01; 6(6):554-61. PubMed ID: 23683737
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug-eluting stent.
    Chen SL, Zhang JJ, Ye F, Tian NL, Sheiban I, Jepson N, Paiboon C, Sansoto T, Kwan TW, Wen SY, Wang HC, Jiang TM, Wang Y, Chen LL, Qiu CG, Zhang YJ, Chen MX, De Maria A.
    Catheter Cardiovasc Interv; 2015 Mar 01; 85 Suppl 1():696-705. PubMed ID: 25631678
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
    Almalla M, Schröder J, Pross V, Marx N, Hoffmann R.
    Catheter Cardiovasc Interv; 2014 May 01; 83(6):881-7. PubMed ID: 23765557
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis.
    Tarantini G, Barioli A, Facchin M, Frigo AC, Napodano M, Buja P, D'Amico G, Iliceto S, Isabella G.
    Coron Artery Dis; 2013 Aug 01; 24(5):440-8. PubMed ID: 23695366
    [Abstract] [Full Text] [Related]

  • 40. Long-term outcomes of routine versus provisional T-stenting for de novo coronary bifurcation lesions: five-year results of the Bifurcations Bad Krozingen I study.
    Ferenc M, Ayoub M, Büttner HJ, Gick M, Comberg T, Rothe J, Valina CM, Hochholzer W, Neumann FJ.
    EuroIntervention; 2015 Dec 01; 11(8):856-9. PubMed ID: 26696453
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.